<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-biomolecules-11-00624">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Renani</surname>
    <given-names>P.G.</given-names>
   </name>
   <name>
    <surname>Taheri</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Rostami</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Farahani</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Abdolkarimi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Abdollahi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Taghizadeh</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hayat</surname>
    <given-names>S.M.G.</given-names>
   </name>
  </person-group>
  <article-title>Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinsonâ€™s disease and epigenetic-based therapies</article-title>
  <source>J. Cell. Physiol.</source>
  <year>2019</year>
  <volume>234</volume>
  <fpage>19307</fpage>
  <lpage>19319</lpage>
  <pub-id pub-id-type="doi">10.1002/jcp.28622</pub-id>
  <?supplied-pmid 30968426?>
  <pub-id pub-id-type="pmid">30968426</pub-id>
 </element-citation>
</ref>
